Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrej Preveden

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Acta Clinica Belgica|August 24, 2022
Prediction parameters of left ventricular diastolic dysfunction improvement in patients after acute coronary syndromeMarija Bjelobrk, Tatjana Miljković, Aleksandra Ilić, et al.
Diseases (Basel, Switzerland)|January 27, 2026
Impact of Chronic Kidney Disease on Clinical, Laboratory, and Echocardiographic Features in Patients with Chronic Heart FailureAnastasija Ilić, Olivera Kovačević, Aleksandra Milovančev, et al.
Clinical Cardiology|March 4, 2020
Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathyMaria Tafelmeier, Andrea Baessler, Stefan Wagner, et al.
International Journal of Molecular Sciences|October 26, 2024
The Influence of Non-Dipping Pattern of Blood Pressure in Gestational Hypertension on Early Onset of Hypertension Later in Life-Single Center Experience in Very-High-Risk Southeast and Central European CountryAleksandra Ilić, Anastazija Stojšić-Milosavljević, Tatjana Miljković, et al.
Pharmaceuticals (Basel, Switzerland)|October 26, 2024
A Machine Learning Approach to Gene Expression in Hypertrophic CardiomyopathyJelena Pavić, Marko Živanović, Irena Tanasković, et al.
European Journal of Heart Failure|May 27, 2024
Sacubitril/valsartan for the treatment of non-obstructive hypertrophic cardiomyopathy: An open label randomized controlled trial (SILICOFCM)Lazar Velicki, Dejana Popovic, Nduka C Okwose, et al.
Medicina (Kaunas, Lithuania)|February 25, 2022
Gender Related Differences in the Clinical Presentation of Hypertrophic Cardiomyopathy-An Analysis from the SILICOFCM DatabaseAndrej Preveden, Miodrag Golubovic, Marija Bjelobrk, et al.
BMC Cardiovascular Disorders|December 10, 2020
Genetic determinants of clinical phenotype in hypertrophic cardiomyopathyLazar Velicki, Djordje G Jakovljevic, Andrej Preveden, et al.
ESC Heart Failure|August 15, 2025
Facilitators, barriers, and insights using an HFA-PEFF-based clinical decision support system: A proof-of-concept studyIsidora Milosavljević, Ivan Petrović, Aleksandra Ilić, et al.
BMJ Open|January 8, 2025
Clinical validation of an artificial intelligence-based decision support system for diagnosis and risk stratification of heart failure (STRATIFYHF): a protocol for a prospective, multicentre longitudinal studySarah Jane Charman, Nduka C Okwose, Amy Groenewegen, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Acta Clinica Belgica|August 24, 2022
Prediction parameters of left ventricular diastolic dysfunction improvement in patients after acute coronary syndromeMarija Bjelobrk, Tatjana Miljković, Aleksandra Ilić, et al.
Diseases (Basel, Switzerland)|January 27, 2026
Impact of Chronic Kidney Disease on Clinical, Laboratory, and Echocardiographic Features in Patients with Chronic Heart FailureAnastasija Ilić, Olivera Kovačević, Aleksandra Milovančev, et al.
Clinical Cardiology|March 4, 2020
Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathyMaria Tafelmeier, Andrea Baessler, Stefan Wagner, et al.
International Journal of Molecular Sciences|October 26, 2024
The Influence of Non-Dipping Pattern of Blood Pressure in Gestational Hypertension on Early Onset of Hypertension Later in Life-Single Center Experience in Very-High-Risk Southeast and Central European CountryAleksandra Ilić, Anastazija Stojšić-Milosavljević, Tatjana Miljković, et al.
Pharmaceuticals (Basel, Switzerland)|October 26, 2024
A Machine Learning Approach to Gene Expression in Hypertrophic CardiomyopathyJelena Pavić, Marko Živanović, Irena Tanasković, et al.
European Journal of Heart Failure|May 27, 2024
Sacubitril/valsartan for the treatment of non-obstructive hypertrophic cardiomyopathy: An open label randomized controlled trial (SILICOFCM)Lazar Velicki, Dejana Popovic, Nduka C Okwose, et al.
Medicina (Kaunas, Lithuania)|February 25, 2022
Gender Related Differences in the Clinical Presentation of Hypertrophic Cardiomyopathy-An Analysis from the SILICOFCM DatabaseAndrej Preveden, Miodrag Golubovic, Marija Bjelobrk, et al.
BMC Cardiovascular Disorders|December 10, 2020
Genetic determinants of clinical phenotype in hypertrophic cardiomyopathyLazar Velicki, Djordje G Jakovljevic, Andrej Preveden, et al.
ESC Heart Failure|August 15, 2025
Facilitators, barriers, and insights using an HFA-PEFF-based clinical decision support system: A proof-of-concept studyIsidora Milosavljević, Ivan Petrović, Aleksandra Ilić, et al.
BMJ Open|January 8, 2025
Clinical validation of an artificial intelligence-based decision support system for diagnosis and risk stratification of heart failure (STRATIFYHF): a protocol for a prospective, multicentre longitudinal studySarah Jane Charman, Nduka C Okwose, Amy Groenewegen, et al.
Pageof 3